|
Monday, 08/02/2010
|
Meta-Analysis: Current State, Recent Developments, and Unresolved Problems
Dalene Stangl, Duke University
|
Validating Surrogate Endpoints from an Information Theory Perspective
Ariel Alonso Abad, Interuniversity Institute for Biostatistics and Statistical Bioinformatics
9:15 AM
|
Bayesian Meta-Analysis of Rare Events Incorporating Historical Controls
Yan Zheng, sanofi-aventis; Xin Zhi, sanofi-aventis
2:05 PM
|
Bayesian Meta-Analysis of Genetic Association Studies: Effective Combining Evidence and Efficent Handling Missing Data
Xiaoquan Wen, The University of Chicago; Matthew Stephens, The University of Chicago
2:05 PM
|
An Individual-Patient Meta-Analytic Mixed Model with Repeated Measures and Time-Dependent Covariates: An Application to Adverse Event Data
Sofia Paul, Novartis Pharmaceuticals Corporation; Stephanie Ann Kovalchik, University of California, Los Angeles; Jing Hu, Novartis Pharmaceuticals Corporation; Glen Laird, Novartis Pharmaceuticals Corporation
2:20 PM
|
Method and Application of Meta-Analysis in Cancer Trials
Xiaoling Wu, Bristol-Myers Squibb; Joseph Pultz, Bristol-Myers Squibb; Andrew Damokosh, Bristol-Myers Squibb; Thomas Kelleher, Bristol-Myers Squibb
2:35 PM
|
Potential Problems with Tian, Cai, Pfeffer, Piankov, Cremieux, and Wei's Exact Stratified Analysis of Rosiglitazone Cardiovascular Deaths
Fraser Smith, FDA/CDER
2:50 PM
|
Meta-Analysis of Diagnostic Test Characteristics in the Absence of a Gold Standard Reference Test
Nandini Dendukuri, McGill University; Ian Schiller, McGill University; Lawrence Joseph, McGill University; Madhukar Pai, McGill University
3:05 PM
|
Evaluation of Design Parameters for an Adaptive Seamless Phase 2b/3 Trial
Susan Y. Zhou, CDER/FDA; Greg Soon, CDER/FDA; Xiao Ding, CDER/FDA; JungYeon Park, CDER/FDA; EunYoung Kim, CDER/FDA; Sue-Jane Wang, FDA
3:05 PM
|
|
Tuesday, 08/03/2010
|
Depression, Fracture Risk, and Bone Loss: A Meta-Analysis of Cohort Studies
Qing Wu, Mayo Clinic; Jianing Liu, Arizona State University; Juan F. Gallegos-Orozco, Mayo Clinic; Joseph G. Hentz, Mayo Clinic
|
Fixed vs. Mixed Parameterization in Logistic Regression: Application to Meta-Analysis
Chin-Fang Weng, University of Maryland
|
Stable Gene Expression Index in Integrative Analysis
Anna Elizabeth Campain, University of Sydney; Jean Yang, University of Sydney; Francine Marques, University of Sydney; Brian Morris, University of Sydney
|
Methodological Issues in the Meta-Analysis of Observational Studies
Lauren Griffith, McMaster University
8:35 AM
|
Combination of Confidence Distributions (CDs) and an Efficient Approach for Meta-Analysis of Heterogeneous Studies
Dungang Liu, Rutgers University; Regina Liu, Rutgers University; Minge Xie, Rutgers University
8:50 AM
|
A Framework for the Meta-Analysis of Survey Data
Karla M.P. Fox, Statistics Canada
9:25 AM
|
Meta-Analysis for Rare Adverse Event Data from Clinical Trials
Brenda Crowe, Eli Lilly and Company
10:35 AM
|
Evaluating Cardiovascular Risk in Diabetes Clinical Trials: Lessons Learned from Saxagliptin
J Mark Donovan, Bristol-Myers Squibb
10:35 AM
|
Multiplicity Issues in Meta-Analyses to Rule Out an Unacceptable Cardiovascular Risk
Stefan Hantel, Boehringer Ingelheim Pharmaceuticals, Inc.
10:55 AM
|
Evaluating Cardiovascular Risk in Diabetes Clinical Trials: An FDA Statistician's Perspective
Jon Todd Sahlroot, FDA
11:15 AM
|
Nonidentifiability Issue in Meta-Analysis in the Presence of Publication Bias
Peter Song, University of Michigan; Youna Hu, University of Michigan; Meihua Wu, University of Michigan
11:55 AM
|
Ambient Air Pollutants and Mortality: A Meta-Analysis
Elizabeth Anne Stanwyck, University of Maryland Baltimore County; Bimal K. Sinha, U.S. Environmental Protection Agency
2:50 PM
|
|
Wednesday, 08/04/2010
|
Heterogeneity of Variance in One-Way Random Effect Model: A Meta-Analysis Review of the National Health Interview Survey Data
Abera Wouhib, National Center for Health Statistics; Myron Katzoff, CDC; Meena Khare, National Center for Health Statistics
9:35 AM
|
Meta-Analysis of Survey Data to Estimate the Size of the Population of Men Who Have Sex with Men for Calculating HIV Rates
Christopher H. Johnson, CDC; David Purcell, CDC; Amy Lansky, CDC; Joseph Prejean, CDC; Paul Denning, CDC; Nicole Crepaz, CDC; Zaneta Gaul, CDC; Renee Stein, CDC; Zaneta Gaul, CDC
9:35 AM
|
Sparse Data in Meta-Analysis: Parametric and Semiparametric Models and Parameterization Issues
Arpita Chatterjee, Northern Illinois University; Sanjib Basu, Northern Illinois University
11:15 AM
|
Presentation of Advanced Statistical Modeling Topics in the Graduate Dental Educational Setting
Deborah V. Dawson, The University of Iowa College of Dentistry
11:50 AM
|
On the meta-Analysis of Genomewide Association Studies: A Robust and Efficient Approach to Combine Population and Family-Based Studies
Christoph Lange, Harvard School of Public Health; Sungho Won, Chung-Ang University
2:25 PM
|
|
Thursday, 08/05/2010
|
Statistical Issues of Meta-Analysis Practices in Drug-Eluting Stent Data
Hsini Terry Liao, Boston Scientific Corporation
8:35 AM
|
Numerical Approximation of the Likelihood of Correlation Matrices
Myung Soon Song, University of Pittsburgh
8:50 AM
|
Considerations for Design and Data Analysis of Adaptive Superiority/Noninferiority Cardiovascular Trials
Hui Quan, sanofi-aventis; Mingyu Li, Celgene Corporation; Peng-Liang Zhao, sanofi-aventis; Meehyung Cho, sanofi-aventis; Ji Zhang, Sanofi-Aventis; Yujun Wu, Sanofi-Aventis
10:35 AM
|
Bayesian Hierarchical Models for Detecting Safety Signals in Clinical Trials
Haijun Ma, Amgen Inc.; Amy Xia, Amgen Inc.; Bradley P. Carlin, University of Minnesota
10:35 AM
|
Challenges in the Conduct of Clinical Trials in the Australasian Region
Val Gebski, University of Sydney
11:05 AM
|
|